Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Cardiology
|
May 26, 2012
The right ventricle in health and disease: insights into physiology, pathophysiology and diagnostic management
Stavros Apostolakis, Stavros Konstantinides
Acta Pharmacologica Sinica
|
August 27, 2013
Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
Stavros Apostolakis, Demetrios Spandidos
Expert Opinion on Investigational Drugs
|
May 24, 2012
Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban
Stavros Apostolakis, Gregory Y H Lip
BMJ Clinical Evidence
|
July 2, 2011
Atrial fibrillation (acute onset)
Gregory Y H Lip, Stavros Apostolakis
Expert Opinion on Investigational Drugs
|
April 29, 2014
Desmoteplase as a potential treatment for cerebral ischaemia
Rikesh Patel, Sevasti Ispoglou, Stavros Apostolakis
BMJ Clinical Evidence
|
November 29, 2014
Atrial fibrillation (acute onset)
Gregory Y H Lip, Stavros Apostolakis
Acta Pharmacologica Sinica
|
August 17, 2010
Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias
Stavros Apostolakis, Virginia Amanatidou, Demetrios A Spandidos
The Pediatric Infectious Disease Journal
|
December 25, 2008
Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection
Virginia Amanatidou, Stavros Apostolakis, Demetrios A Spandidos
Hospital Practice (1995)
|
March 8, 2013
A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice
Charalampos Kasmeridis, Gregory Y Lip, Stavros Apostolakis
Hospital Practice (1995)
|
March 8, 2013
Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants
Yutao Guo, Gregory Y Lip, Stavros Apostolakis
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Cardiology
|
May 26, 2012
The right ventricle in health and disease: insights into physiology, pathophysiology and diagnostic management
Stavros Apostolakis, Stavros Konstantinides
Acta Pharmacologica Sinica
|
August 27, 2013
Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
Stavros Apostolakis, Demetrios Spandidos
Expert Opinion on Investigational Drugs
|
May 24, 2012
Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban
Stavros Apostolakis, Gregory Y H Lip
BMJ Clinical Evidence
|
July 2, 2011
Atrial fibrillation (acute onset)
Gregory Y H Lip, Stavros Apostolakis
Expert Opinion on Investigational Drugs
|
April 29, 2014
Desmoteplase as a potential treatment for cerebral ischaemia
Rikesh Patel, Sevasti Ispoglou, Stavros Apostolakis
BMJ Clinical Evidence
|
November 29, 2014
Atrial fibrillation (acute onset)
Gregory Y H Lip, Stavros Apostolakis
Acta Pharmacologica Sinica
|
August 17, 2010
Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias
Stavros Apostolakis, Virginia Amanatidou, Demetrios A Spandidos
The Pediatric Infectious Disease Journal
|
December 25, 2008
Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection
Virginia Amanatidou, Stavros Apostolakis, Demetrios A Spandidos
Hospital Practice (1995)
|
March 8, 2013
A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice
Charalampos Kasmeridis, Gregory Y Lip, Stavros Apostolakis
Hospital Practice (1995)
|
March 8, 2013
Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants
Yutao Guo, Gregory Y Lip, Stavros Apostolakis
Page
of 9